Ainos Inc AIMD 深 沪
已收盘 10-03 16:00:00 美东时间
3.53
-0.060
-1.67%
华盛通- 最 高3.6391
- 今 开3.59
- 成交量 2.51万股
- 最 低 3.51
- 昨 收 3.59
- 总市值 1479.78万
- 52周最高 5.00
- 市盈率 静 --
- 换手率 0.60%
- 52周最低 2.00
- 委 比 88.82%
- 总股本 419.20万
- 历史最高 93.75
- 量 比 0.48
- 振 幅 3.60%
- 历史最低 2.00
- 每 手 1
- 风险率 0.49%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Ainos Secures Seven New Patents In Europe, Germany, Taiwan, And China, Enhancing Its AI Nose Digital Olfaction Platform For Robotics Applications
Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent digitization, today announced it has secured seven new patents in Europe, Germany, Taiwan and China that strengthen its AI
09-30 20:32
Ainos Files Prospectus for Additional Share Offering
Ainos ( ($AIMD) ) has provided an announcement. Ainos, Inc. entered into an At ...
09-08 21:29
Ainos Launches Patented AI Nose Platform For Industrial And Healthcare Markets, Unveils SmellTech-As-A-Service At Automation Taipei 2025
Patented AI Olfaction Platform Targets Semiconductor, Smart Factory, and Hospital Markets With First Deployments UnderwaySmellTech-as-a-Service Subscription Delivers AI Upgrades and Analytics, Keeping Enterprises Ahead
08-14 21:39
Ainos Q2 EPS $(0.99) Up From $(2.45) YoY, Sales $4.663K
Ainos (NASDAQ:AIMD) reported quarterly losses of $(0.99) per share. This is a 59.59 percent increase over losses of $(2.45) per share from the same period last year. The company reported $4.663 thousand in sales this
08-14 04:20
Ainos, Inc Announces Its Investigational Low-Dose Oral Interferon-Alpha Drug Candidate, Veldona Has Received Formal Approval From Taiwan's Food And Drug Administration To Initiate A Clinical Study For Primary Sjögren's Syndrome
Advancing a Novel, Side-Effect-Free Treatment for a Rare Yet Widely Underserved Autoimmune DiseaseAinos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a Texas incorporated, dual-platform AI and biotech
08-04 20:04
Ainos Regains Nasdaq Compliance, Accelerates AI Nose Platform Commercialization With 90-Day Execution Plan
Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a pioneer in AI-powered scent digitization, today announced it has regained compliance with the minimum bid price requirement for continued listing on
07-16 20:09
Ainos shares are trading higher after the company completed its 1-for-5 stock consolidation.
Ainos shares are trading higher after the company completed its 1-for-5 stock c...
07-01 00:49
Ainos To Implement Consolidation Of Its Common Stock, Effective June 30, 2025
Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that it will implement a consolidation of its common stock ("stock consolidation"), effective at the opening of trading on June 30, 2025.
06-26 23:02
Ainos Partners with Kenmec for AI Integration
Ainos ( ($AIMD) ) just unveiled an update. On June 24, 2025, Ainos, Inc. announ...
06-24 20:28
Ainos Q1 EPS $(0.21) Up From $(0.57) YoY, Sales $106.21K Up From $20.73K YoY
Ainos (NASDAQ:AIMD) reported quarterly losses of $(0.21) per share. This is a 63.16 percent increase over losses of $(0.57) per share from the same period last year. The company reported $106.21 thousand in sales this
05-12 20:13
